We describe the demographics, clinical characteristics, and prognosis of cancer patients with COVID-19 infection.
•
Cancer patients had a high infection rate of SARS-CoV-2 and were easy to become severe or critical cases.
•
Among cancer patients with COVID-19, the numbers of neutrophil, NLR(ratio of neutrophil to lymphocyte, IL-6, LDH and PCT in the severe/critical group were significantly higher than those in the mild group.
